Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

NCT06530303 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Colon Cancer
Rectum Cancer

Interventions

BIOLOGICAL: Tumor Infiltrating Lymphocytes (TIL)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
DRUG: Pembrolizumab

Sponsor

Essen Biotech